Christopher P. Molineaux - Net Worth and Insider Trading
Christopher P. Molineaux Net Worth
The estimated net worth of Christopher P. Molineaux is at least $9,065 dollars as of 2024-10-02. Christopher P. Molineaux is the Director of Aclaris Therapeutics Inc and owns about 7,682 shares of Aclaris Therapeutics Inc (ACRS) stock worth over $9,065. Details can be seen in Christopher P. Molineaux's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Christopher P. Molineaux has not made any transactions after 2018-04-06 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Christopher P. Molineaux
Christopher P. Molineaux Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Christopher P. Molineaux owns 1 companies in total, including Aclaris Therapeutics Inc (ACRS) .
Click here to see the complete history of Christopher P. Molineaux’s form 4 insider trades.
Insider Ownership Summary of Christopher P. Molineaux
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2018-04-06 | director |
Christopher P. Molineaux Latest Holdings Summary
Christopher P. Molineaux currently owns a total of 1 stock. Christopher P. Molineaux owns 7,682 shares of Aclaris Therapeutics Inc (ACRS) as of April 6, 2018, with a value of $9,065.
Latest Holdings of Christopher P. Molineaux
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACRS | Aclaris Therapeutics Inc | 2018-04-06 | 7,682 | 1.18 | 9,065 |
Holding Weightings of Christopher P. Molineaux
Christopher P. Molineaux Form 4 Trading Tracker
According to the SEC Form 4 filings, Christopher P. Molineaux has made a total of 0 transactions in Aclaris Therapeutics Inc (ACRS) over the past 5 years. The most-recent trade in Aclaris Therapeutics Inc is the sale of 2,300 shares on April 6, 2018, which brought Christopher P. Molineaux around $37,996.
Insider Trading History of Christopher P. Molineaux
- 1
Christopher P. Molineaux Trading Performance
Christopher P. Molineaux Ownership Network
Christopher P. Molineaux Owned Company Details
What does Aclaris Therapeutics Inc do?
Who are the key executives at Aclaris Therapeutics Inc?
Christopher P. Molineaux is the director of Aclaris Therapeutics Inc. Other key executives at Aclaris Therapeutics Inc include Chief Scientific Officer Joseph Monahan , Chief Financial Officer Kevin Balthaser , and Chief Business Officer James Loerop .
Aclaris Therapeutics Inc (ACRS) Insider Trades Summary
Over the past 18 months, Christopher P. Molineaux made no insider transaction in Aclaris Therapeutics Inc (ACRS). Other recent insider transactions involving Aclaris Therapeutics Inc (ACRS) include a net purchase of 4,854,052 shares made by Braden Michael Leonard , a net sale of 18,000 shares made by Joseph Monahan , and a net purchase of 14,705 shares made by James Loerop .
In summary, during the past 3 months, insiders sold 0 shares of Aclaris Therapeutics Inc (ACRS) in total and bought 1,154,418 shares, with a net purchase of 1,154,418 shares. During the past 18 months, 18,000 shares of Aclaris Therapeutics Inc (ACRS) were sold and 4,878,247 shares were bought by its insiders, resulting in a net purchase of 4,860,247 shares.
Aclaris Therapeutics Inc (ACRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Aclaris Therapeutics Inc Insider Transactions
Christopher P. Molineaux Mailing Address
Above is the net worth, insider trading, and ownership report for Christopher P. Molineaux. You might contact Christopher P. Molineaux via mailing address: C/o Aclaris Therapeutics, Inc., 101 Lindenwood Drive, Suite 400, Malvern Pa 19355.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
